Amy A. Pruitt

4.8k total citations · 1 hit paper
58 papers, 2.9k citations indexed

About

Amy A. Pruitt is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Amy A. Pruitt has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Epidemiology and 15 papers in Neurology. Recurrent topics in Amy A. Pruitt's work include Polyomavirus and related diseases (14 papers), Neurological Complications and Syndromes (12 papers) and Glioma Diagnosis and Treatment (11 papers). Amy A. Pruitt is often cited by papers focused on Polyomavirus and related diseases (14 papers), Neurological Complications and Syndromes (12 papers) and Glioma Diagnosis and Treatment (11 papers). Amy A. Pruitt collaborates with scholars based in United States, Spain and Greece. Amy A. Pruitt's co-authors include Fred H. Hochberg, Robert H. Rubin, Gordon W. Duncan, Adolf W. Karchmer, Myrna R. Rosenfeld, David C. Hooper, Corey C. Ford, Andrew Goodman, Robert P. Lisak and Lawrence W. Myers and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Neurology.

In The Last Decade

Amy A. Pruitt

55 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assumptions in the radiotherapy of glioblastoma

1980 772 citations Fred H. Hochberg, Amy A. Pruitt profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy A. Pruitt United States	23	958	719	706	676	649	58	2.9k
Jon Glass United States	27	1.4k 1.5×	571 0.8×	559 0.8×	626 0.9×	1.0k 1.6×	68	2.8k
Majda M. Thurnher Austria	30	393 0.4×	368 0.5×	518 0.7×	405 0.6×	572 0.9×	87	2.5k
Geraldine Cambridge United Kingdom	41	1.2k 1.3×	569 0.8×	542 0.8×	853 1.3×	256 0.4×	118	6.1k
Hidehiro Takei United States	28	380 0.4×	463 0.6×	361 0.5×	263 0.4×	494 0.8×	177	2.5k
Luc Mouthon France	38	523 0.5×	1.6k 2.2×	1.2k 1.7×	1.1k 1.6×	296 0.5×	166	5.4k
Phuc LeHoang France	42	232 0.2×	552 0.8×	1.0k 1.5×	863 1.3×	1.0k 1.6×	201	5.7k
Bahram Bodaghi France	51	251 0.3×	1.3k 1.8×	1.6k 2.3×	846 1.3×	1.1k 1.8×	363	9.1k
Nuzhat Husain India	33	414 0.4×	413 0.6×	399 0.6×	550 0.8×	279 0.4×	239	3.8k
Adekunle M. Adesina United States	29	1.2k 1.2×	444 0.6×	543 0.8×	132 0.2×	554 0.9×	111	3.1k
Aharon Kessel Israel	36	612 0.6×	231 0.3×	621 0.9×	703 1.0×	110 0.2×	135	3.7k

Countries citing papers authored by Amy A. Pruitt

Since Specialization

Citations

This map shows the geographic impact of Amy A. Pruitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy A. Pruitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy A. Pruitt more than expected).

Fields of papers citing papers by Amy A. Pruitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy A. Pruitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy A. Pruitt. The network helps show where Amy A. Pruitt may publish in the future.

Co-authorship network of co-authors of Amy A. Pruitt

This figure shows the co-authorship network connecting the top 25 collaborators of Amy A. Pruitt. A scholar is included among the top collaborators of Amy A. Pruitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy A. Pruitt. Amy A. Pruitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thebault, Simon, Leah Zuroff, Matthew K. Schindler, et al.. (2023). Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 8 indexed citations

Ford, Corey C., Jeffrey A. Cohen, Andrew Goodman, et al.. (2022). Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study. Multiple Sclerosis Journal. 28(11). 1729–1743. 2 indexed citations

Gill, Alexander J., et al.. (2019). A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes. Journal of Neuroimmunology. 334. 576980–576980. 50 indexed citations

Holtzman, David M. & Amy A. Pruitt. (2016). Multiple Sclerosis Treatments. Oxford University Press eBooks. 1 indexed citations

Pruitt, Amy A.. (2015). Medical Management of Patients With Brain Tumors. CONTINUUM Lifelong Learning in Neurology. 21(2). 314–331. 18 indexed citations

Pruitt, Amy A.. (2014). Infections of the Cerebellum. Neurologic Clinics. 32(4). 1117–1131. 34 indexed citations

Pruitt, Amy A.. (2014). Nervous system viral infections in immunocompromised hosts. Handbook of clinical neurology. 123. 685–704. 5 indexed citations

Pruitt, Amy A.. (2013). Neurologic Complications of Infective Endocarditis. Current Treatment Options in Neurology. 15(4). 465–476. 15 indexed citations

Richie, Megan & Amy A. Pruitt. (2012). Spinal Cord Infections. Neurologic Clinics. 31(1). 19–53. 8 indexed citations

10.

Minagar, Alireza, et al.. (2012). The Spinal Cord. Neurologic Clinics. 31(1). 1–18. 92 indexed citations

11.

Pruitt, Amy A.. (2012). CNS Infections in Patients With Cancer. CONTINUUM Lifelong Learning in Neurology. 18(2). 384–405. 16 indexed citations

12.

Pruitt, Amy A.. (2011). Medical Management of Patients With Brain Tumors. Current Treatment Options in Neurology. 13(4). 413–426. 22 indexed citations

13.

Pruitt, Amy A.. (2011). Neurologic Infectious Disease Emergencies. Neurologic Clinics. 30(1). 129–159. 6 indexed citations

14.

Pruitt, Amy A.. (2005). Treatment of medical complications in patients with brain tumors. Current Treatment Options in Neurology. 7(4). 323–336. 13 indexed citations

15.

Pruitt, Amy A. & Myrna R. Rosenfeld. (2005). 10 Questions About Temozolomide and the Treatment of Brain Tumors. The Neurologist. 11(6). 362–365. 5 indexed citations

16.

Johnson, K. P., Benjamin Brooks, Corey C. Ford, et al.. (2003). Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial. Multiple Sclerosis Journal. 9(6). 585–591. 50 indexed citations

17.

Buckanovich, Ronald J., Carrie Tompkins Stricker, Selina M. Luger, et al.. (2002). Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy. Annals of Hematology. 81(7). 410–413. 43 indexed citations

18.

Johnson, K. P., Benjamin Brooks, Corey C. Ford, et al.. (2000). Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Multiple Sclerosis Journal. 6(4). 255–266. 170 indexed citations

19.

Pruitt, Amy A.. (1998). INFECTIONS OF THE NERVOUS SYSTEM. Neurologic Clinics. 16(2). 419–447. 25 indexed citations

20.

Hochberg, Fred H., Amy A. Pruitt, Deborah O. Beck, Gérard Debrun, & Kenneth L. Davis. (1985). The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma. Journal of neurosurgery. 63(6). 876–880. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact